Johnson & Johnson is raising its full-year profit forecast as drug sales outpace devices
- Johnson: 24 events in the last 90 days
- Previous: 1 days earlier · Sources: Eagles to keep retired Johnson on roster amid O-line changes
What happened
The health care giant now expects adjusted EPS of $11.05 to $11.15 for 2026, and is leaning toward spinning off its orthopedics unit
Summary assembled by rule from the sources below